Loading…
ABIVAX Société Anonyme is projected to rise to $159.56 by 2027, a +23% move from its current price of $129.73. ABVX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $126.30 | $129.77 | $133.33 | +0.03% |
| May 30 | $124.93 | $129.80 | $134.87 | +0.06% |
| May 31 | $123.89 | $129.84 | $136.08 | +0.09% |
| Jun 1 | $123.03 | $129.88 | $137.11 | +0.11% |
| Jun 2 | $122.28 | $129.92 | $138.03 | +0.14% |
| Jun 3 | $121.61 | $129.95 | $138.87 | +0.17% |
| Jun 4 | $121.00 | $129.99 | $139.65 | +0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $121.00 | $129.99 | $139.65 | +0.20% |
| Week 2 | $117.70 | $130.25 | $144.14 | +0.40% |
| Week 3 | $115.28 | $130.51 | $147.76 | +0.60% |
| Week 4 | $113.31 | $130.77 | $150.93 | +0.80% |
| Week 5 | $111.64 | $131.04 | $153.81 | +1.01% |
| Week 6 | $110.16 | $131.30 | $156.49 | +1.21% |
| Week 7 | $108.84 | $131.56 | $159.03 | +1.41% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ABIVAX Société Anonyme is a clinical-stage biotechnology company developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate obefazimod is in Phase 3 clinical development for moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease.
ABIVAX was incorporated in 2013 and is headquartered in Paris, France. It operates in the Healthcare sector.
ABIVAX Société Anonyme (ABVX) is a healthcare stock with a current price of $121.99 and a market cap of $9.67B. It is ranked 931 by market capitalization and overall market positioning.
A major floor 24.1% below — a decisive break under it would weaken the trend.
The nearest floor, 18.1% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 12.1% above — clearing it would confirm fresh momentum.
Key ABVX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ABVX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $124.41 | Buy | $124.85 | Buy |
| MA 10 | $120.68 | Buy | $122.53 | Buy |
| MA 20 | $120.32 | Buy | $120.75 | Buy |
| MA 50 | $118.09 | Buy | $119.07 | Buy |
| MA 100 | $118.68 | Buy | $115.81 | Buy |
| MA 200 | $108.67 | Buy | $101.28 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.32 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 147.71 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.92 | Buy |
| ROC (12) | 5.69 | Buy |
| Bollinger %B (20,2) | 0.94 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.12 | Buy |
| Awesome (5,34) | 4.97 | Buy |
| Ultimate (7,14,28) | 72.39 | Sell |
| Momentum (10) | 8.34 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 128.24 | Buy |
| ADX (14) | 12.03 | Neutral |
| ATR (14) | 3.01 | Info |
The 30-day technical picture shows a bullish sentiment with RSI14 at 50, and moving averages at SMA50 $117.73 and SMA200 $108.09. Key support sits at $106.24 and resistance at $126.54, framing a 30-day price range from $101.85 to $146.11.
Annualized volatility is 50%, highlighting notable price movement within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $101.50 | $129.73 | $185.75 | 0% | Neutral | |
| $126.65 | $159.56 | $212.91 | +23% | Bullish | |
| $139.34 | $180.34 | $249.31 | +39% | Bullish | |
| $171.27 | $226.70 | $322.32 | +75% | Bullish | |
| $209.01 | $282.25 | $410.93 | +118% | Bullish | |
| $229.93 | $316.20 | $470.04 | +144% | Bullish | |
| $229.76 | $321.39 | $486.76 | +148% | Bullish | |
| $249.95 | $355.26 | $547.26 | +174% | Bullish | |
| $273.31 | $394.41 | $617.13 | +204% | Bullish | |
| $300.54 | $440.06 | $698.63 | +239% | Bullish | |
| $409.81 | $641.05 | $1,081.69 | +394% | Bullish | |
| $891.85 | $1,563.26 | $2,883.50 | +11.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $101.50 | $129.73 | $152.82 | +0.00% |
| June 2026 | $113.98 | $133.83 | $160.86 | +3.16% |
| July 2026 | $112.47 | $133.16 | $162.21 | -0.50% |
| August 2026 | $111.49 | $132.88 | $163.53 | -0.22% |
| September 2026 | $115.85 | $138.81 | $172.26 | +4.47% |
| October 2026 | $119.61 | $144.04 | $180.11 | +3.76% |
| November 2026 | $119.11 | $144.05 | $181.32 | +0.01% |
| December 2026 | $120.75 | $146.66 | $185.75 | +1.81% |
Click any year to see its month-by-month ABVX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ABVX to range from $101.50 to $185.75 through 2026. The $129.73 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ABVX price prediction for 2027 points to an average of $159.56 (low $126.65, high $212.91) — a potential gain of +23% on today's $129.73. Buyers look set to stay in control over this stretch.
In 2028, ABVX is projected to trade between $139.34 and $249.31, averaging $180.34 — a potential gain of +39% from today's $129.73. That is up +13% on the projected 2027 average. Momentum favours further upside here.
ABIVAX Société Anonyme's 2029 outlook centres on $226.70, within a $171.27 to $322.32 range. That is up +26% on the projected 2028 average. That marks a +75% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ABVX could reach as high as $410.93, with a base case around $282.25 and support toward $209.01 — roughly +118% from $129.73. Momentum favours further upside here.
Expect ABVX to range from $229.93 to $470.04 through 2031. The $316.20 average target implies a +144% move from current prices. That is up +12% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ABVX price prediction for 2032 points to an average of $321.39 (low $229.76, high $486.76) — a potential gain of +148% on today's $129.73. Momentum favours further upside here.
In 2033, ABVX is projected to trade between $249.95 and $547.26, averaging $355.26 — a potential gain of +174% from today's $129.73. That is up +11% on the projected 2032 average. Buyers look set to stay in control over this stretch.
ABIVAX Société Anonyme's 2034 outlook centres on $394.41, within a $273.31 to $617.13 range. That is up +11% on the projected 2033 average. That marks a +204% change versus current levels. Momentum favours further upside here.
By 2035, ABVX could reach as high as $698.63, with a base case around $440.06 and support toward $300.54 — roughly +239% from $129.73. Buyers look set to stay in control over this stretch.
Expect ABVX to range from $409.81 to $1,081.69 through 2040. The $641.05 average target implies a +394% move from current prices. That is up +46% on the projected 2035 average. Momentum favours further upside here.
The ABVX price prediction for 2050 points to an average of $1,563.26 (low $891.85, high $2,883.50) — a potential gain of +11.1x on today's $129.73. Buyers look set to stay in control over this stretch.
Investing $1,000 in ABVX today (≈ 7.708317 ABVX) could be worth
$12,050.08
+$11,050.08 (+1105%) by 2050 · US Dollar
Based on the average projected ABVX price of $1,563.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ABVXwould be worth at today's price.
$1,000 invested in ABVX on May 27, 2025 (≈ 175.746923 ABVX) would be worth
$22,799.65
+$21,799.65 (+2180.0%) today · 22.80× · US Dollar
Based on a ABVX entry price of $5.69 vs. today's $129.73.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $119.9 | $1,081.98 | +8.2% |
| 1 month ago | $111.9 | $1,159.34 | +15.9% |
| 3 months ago | $119.47 | $1,085.88 | +8.6% |
| 6 months ago | $124.83 | $1,039.25 | +3.9% |
| 1 year ago | $5.69 | $22,799.65 | +2180.0% |
| All time (2.6y) ago | $8.3 | $15,630.12 | +1463.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ABVX forecast.
Our base-case forecast reaches $260.00 around 2030.
Implied market cap at $260.00: $20.72B
The multi-year forecast reveals substantial upside, with the 2026 average at $121.99 (ROI 0, sentiment NEUTRAL). The path progresses to 2027 average $145.95 (ROI 19.6, NEUTRAL), 2028 average $161.00 (ROI 32, BULLISH), and 2029 average $201.87 (ROI 65.5, BULLISH).
By 2030, the average is $247.76 (ROI 103.1, BULLISH), and by 2050 the average reaches $1,256.96 (ROI 930.4, BULLISH), with a 2050 max of $2,327.81 and a 2040 max of $882.94. The forecast indicates rising averages and strong upside potential over the long term, though these are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $247.76; min $183.09; max $361.60; ROI 103.1%; sentiment BULLISH.
Forecasts show upside, with 2030 avg $247.76 (ROI 103.1%) and 2050 avg $1,256.96 (ROI 930.4%), but these are estimates and not guarantees.
Yes—the 2050 forecast max is $2,327.81, implying a potential to exceed $1,000.
Current price $121.99; market cap $9.67B.
Avg $201.87; min $152.22; max $287.67; ROI 65.5%; sentiment BULLISH.
ABIVAX Société Anonyme Community Discussion
0Share your ABIVAX Société Anonyme price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.